MedTrace Logo

Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results

NCT05226572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 462

Last updated 2022-11-08

No results posted yet for this study

Summary

The primary aim of REuBio study is to evaluate the diagnostic accuracy of repeated endoscopic ultrasound-guided fine needle biopsy after a previous non-diagnostic or inconclusive EUS-guided sampling of solid pancreatic lesions.

Conditions

  • Pancreatic Adenocarcinoma
  • Pancreas Cancer
  • Pancreas Metastases

Interventions

DIAGNOSTIC_TEST

endoscopic ultrasound-guided fine needle biopsy

repeated endoscopic ultrasound-guided fine needle-biopsy after a previous non diagnostic or incoclusive endoscopic ultrasound-guided tissue aquisition for pancreatic solid lesions.

Sponsors & Collaborators

  • University of Bologna

    lead OTHER

Principal Investigators

  • Pietro Fusaroli, Professor · University of Bologna

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2022-05-23
Completion
2022-05-23

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05226572 on ClinicalTrials.gov